Related references
Note: Only part of the references are listed.Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital
Felice N. van Erning et al.
ACTA ONCOLOGICA (2014)
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
Roberta De Angelis et al.
LANCET ONCOLOGY (2014)
Timed Up & Go: A Screening Tool for Predicting 30-Day Morbidity in Onco-Geriatric Surgical Patients? A Multicenter Cohort Study
Monique G. Huisman et al.
PLOS ONE (2014)
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
A. J. M. Beijers et al.
SUPPORTIVE CARE IN CANCER (2014)
Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007
Camille Maringe et al.
ACTA ONCOLOGICA (2013)
Liver only metastatic disease in patients with metastatic colorectal cancer: Impact of surgery and chemotherapy
Sunita Padman et al.
ACTA ONCOLOGICA (2013)
Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older
F. N. van Erning et al.
ANNALS OF ONCOLOGY (2013)
Influence of Comorbidity and Age on 1-, 2-, and 3-Month Postoperative Mortality Rates in Gastrointestinal Cancer Patients
Yvette R. B. M. van Gestel et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial
D. Pettersson et al.
BRITISH JOURNAL OF SURGERY (2013)
Adjuvant chemotherapy for stage III colon cancer in the oldest old
Anasooya Abraham et al.
CANCER (2013)
Safety and Effectiveness of Oxaliplatin-Based Chemotherapy Regimens in Adults 75 Years and Older With Colorectal Cancer
Nadine Jackson McCleary et al.
CLINICAL COLORECTAL CANCER (2013)
Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989-2008
L. N. van Steenbergen et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 19952010
N. J. van Leersum et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Meta-analysis of randomized trials comparing endoscopic stenting and surgical decompression for colorectal cancer obstruction
Vincenzo Cennamo et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database
Nadine J. McCleary et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients
Thomas Aparicio et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2-to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
Floortje Mols et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
David Cunningham et al.
LANCET ONCOLOGY (2013)
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
Herbert I. Hurwitz et al.
ONCOLOGIST (2013)
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
Thierry Andre et al.
CURRENT COLORECTAL CANCER REPORTS (2013)
Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimized
Kok-Yang Tan et al.
AMERICAN JOURNAL OF SURGERY (2012)
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
C. Twelves et al.
ANNALS OF ONCOLOGY (2012)
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C
T. J. Price et al.
ANNALS OF ONCOLOGY (2012)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
Rethinking the Association of High Blood Pressure With Mortality in Elderly Adults The Impact of Frailty
Michelle C. Odden et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Correlation in Rectal Cancer Between Clinical Tumor Response After Neoadjuvant Radiotherapy and Sphincter or Organ Preservation: 10-Year Results of the Lyon R 96-02 Randomized Trial
Cecile Ortholan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
Christophe Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y. Ngan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years
Hanna K. Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
Marije E. Hamaker et al.
LANCET ONCOLOGY (2012)
Comparative outcomes of rectal cancer surgery between elderly and non-elderly patients: a systematic review
Gilles Manceau et al.
LANCET ONCOLOGY (2012)
First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study
Javier Sastre et al.
ONCOLOGIST (2012)
The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer
Marije E. Hamaker et al.
ONCOLOGIST (2012)
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
T. R. Asmis et al.
ANNALS OF ONCOLOGY (2011)
Risk Factors for Mortality in Major Digestive Surgery in the Elderly A Multicenter Prospective Study
Jean-Jacques Duron et al.
ANNALS OF SURGERY (2011)
Importance of the First Postoperative Year in the Prognosis of Elderly Colorectal Cancer Patients
J. W. T. Dekker et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer
B. S. Nedrebo et al.
BRITISH JOURNAL OF SURGERY (2011)
Do Patients Consider Preoperative Chemoradiation for Primary Rectal Cancer Worthwhile?
Erin D. Kennedy et al.
CANCER (2011)
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)
J. Sastre et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals
P. Barthelemy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study
Thomas Aparicio et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients
Pascal Chaibi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival
C. B. M. van den Broek et al.
EJSO (2011)
Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study
L. I. Olsson et al.
EUROPEAN JOURNAL OF CANCER (2011)
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Greg Yothers et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
Daniel G. Haller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
Matthew T. Seymour et al.
LANCET (2011)
The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery
Guus M. J. Bokkerink et al.
BMC SURGERY (2011)
Outcome of surgical treatment of colorectal cancer in the elderly
Andrea Fontani et al.
UPDATES IN SURGERY-ITALY (2011)
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
D. Pettersson et al.
BRITISH JOURNAL OF SURGERY (2010)
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort study
Siri R. Kristjansson et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Treatment of Recurrence After Transanal Endoscopic Microsurgery (TEM) for T1 Rectal Cancer
Pascal G. Doornebosch et al.
DISEASES OF THE COLON & RECTUM (2010)
Should specialized oncogeriatric surgeons operate older unfit cancer patients?
B.L. van Leeuwen et al.
EJSO (2010)
Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome
Mieke J. Aarts et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Adjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon Cancer
Katherine L. Kahn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
James Cassidy et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Niall C. Tebbutt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Surviving Chemotherapy for Colon Cancer and Living with the Consequences
Cindy Tofthagen
JOURNAL OF PALLIATIVE MEDICINE (2010)
Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study
Mark F. Kozloff et al.
ONCOLOGY (2010)
A nationwide audit of the use of radiotherapy for rectal cancer in Italy
G. Gagliardi et al.
TECHNIQUES IN COLOPROCTOLOGY (2010)
Guidelines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society
Luca Ansaloni et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2010)
Outcome of Colonic Surgery in Elderly Patients with Colon Cancer
E. Hermans et al.
JOURNAL OF ONCOLOGY (2010)
Improving outcomes in older people undergoing elective surgery
J. Dhesi
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2010)
Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review
Pascal G. Doornebosch et al.
ACTA ONCOLOGICA (2009)
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
D. Papamichael et al.
ANNALS OF ONCOLOGY (2009)
Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish rectal cancer registry 1995-2004
Barbel Jung et al.
BMC CANCER (2009)
Clinical Trial Enrollment, Patient Characteristics, and Survival Differences in Prospectively Registered Metastatic Colorectal Cancer Patients
Halfdan Sorbye et al.
CANCER (2009)
International Trends in Colorectal Cancer Incidence Rates
Melissa M. Center et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Surgical risk and post-operative complications in older unfit cancer patients
Siri R. Kristjansson et al.
CANCER TREATMENT REVIEWS (2009)
Preferences for Outcomes of Treatment for Rectal Cancer: Patient and Clinician Utilities and Their Application in an Interactive Computer-Based Decision Aid
Lindy M. Masya et al.
DISEASES OF THE COLON & RECTUM (2009)
The cancer survival gap between elderly and middle-aged patients in Europe is widening
Alberto Quaglia et al.
EUROPEAN JOURNAL OF CANCER (2009)
Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis
F. Rondelli et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials
Fairooz F. Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
David Sebag-Montefiore et al.
LANCET (2009)
Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer
James D. Harrison et al.
ARCHIVES OF SURGERY (2008)
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer:: a Phase II study
Eric Francois et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Primary vs. delayed resection for obstructive left-sided colorectal cancer:: Impact of surgery on patient outcome
J. K. Jiang et al.
DISEASES OF THE COLON & RECTUM (2008)
Neoadjuvant Treatment of Rectal Carcinoma: Assessment of Health Care Services by Physicians and Lay Persons
Marko Kornmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer:: Combined analysis of 2,691 patients in randomized controlled trials
Gunnar Folprecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?
Veronique Girre et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2008)
Controversies of total mesorectal excision for rectal cancer in elderly patients
Harm J. T. Rutten et al.
LANCET ONCOLOGY (2008)
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer -: An exploratory cohort of the OPTIMOX1 study
Ari Figer et al.
CANCER (2007)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer
T. Vuong et al.
CLINICAL ONCOLOGY (2007)
The TME trial after a median follow-up of 6 years - Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
Koen C. M. J. Peeters et al.
ANNALS OF SURGERY (2007)
Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?
H. Martijn et al.
EUROPEAN JOURNAL OF CANCER (2007)
Are we undertreating rectal cancer in the elderly? An epidemiologic study
George J. Chang et al.
ANNALS OF SURGERY (2007)
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
Matthew T. Seymour et al.
LANCET (2007)
Frailty in relation to the accumulation of deficits
Kenneth Rockwood et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
J. Philip Kuebler et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Rectal cancer treatment of the elderly
B. H. Endreseth et al.
COLORECTAL DISEASE (2006)
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-06
BC Lembersky et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer
J Couture et al.
DISEASES OF THE COLON & RECTUM (2005)
Improvement in colorectal cancer survival: A population-based study
E Mitry et al.
EUROPEAN JOURNAL OF CANCER (2005)
Trends in the management and survival of digestive tract cancers among patients aged over 80 years
AM Bouvier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer:: European Organisation for Research and Treatment of Cancer Gastrointestinal Group study 40986
CH Köhne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Capecitabine as adjuvant treatment for stage III colon cancer
C Twelves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Time trends in the treatment and survival of recurrences from colorectal cancer
F Guyot et al.
ANNALS OF ONCOLOGY (2005)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Nutritional issues in the care of the elderly patient
F Bozzetti
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
T Aparicio et al.
BRITISH JOURNAL OF CANCER (2003)
What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer
MJ Solomon et al.
DISEASES OF THE COLON & RECTUM (2003)
Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer:: Results of a randomized trial
T André et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial
ML Rothenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort
JZ Ayanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Benefit of operative mortality reduction on colorectal cancer survival
E Mitry et al.
BRITISH JOURNAL OF SURGERY (2002)
Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer - Early results of a phase I/II study
T Vuong et al.
DISEASES OF THE COLON & RECTUM (2002)
Age and adjuvant chemotherapy use after surgery for stage III colon cancer
D Schrag et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Surgery in the elderly: the role of nutritional support
F Bozzetti
CLINICAL NUTRITION (2001)
Frailty in older adults: Evidence for a phenotype
LP Fried et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)
Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population
C Faivre-Finn et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
